Operative stress may affect haemostatic mechanisms through hormonal systems. As 
The endocrine response to surgery is characterized by increased plasma concentrations of stress-related hormones [1] . This response is especially pronounced during cardiopulmonary bypass (CPB) in patients undergoing cardiac surgery [2, 3] . Anaesthesia with large doses of opioids attenuates but does not abolish the stress response to cardiac surgery [4] [5] [6] , while inhalation anaesthesia in small to moderate inspiratory concentrations is less effective [7] [8] [9] .
Surgical stress activates the fibrinolytic system and increases plasma concentrations of coagulation factors with an increase in plasma arginine vasopressin (AVP) concentration [10, 11] . This suggests a possible causal relationship between stress hormones and regulation of haemostasis. Administration of exogenous adrenaline or vasopressin in large physiological concentrations induces increases in plasma concentrations of von Willebrand factor (vWF) and factor VIII :C and activates the fibrinolytic system in healthy volunteers [12] [13] [14] [15] .
Because various hormones seem to be involved in haemostatic regulation, we posed the hypothesis that the endocrine response to cardiac surgery might affect haemostasis. Therefore, we measured plasma concentrations of AVP, catecholamines and coagulation factor in patients undergoing coronary artery bypass grafting (CABG). Anaesthesia was designed to blunt the endocrine response to surgery in one group of patients, while a second group (stress group) was anaesthetized with a combination of anaesthetics thought not to abolish effectively the hormonal changes.
PATIENTS AND METHODS
The study was approved by the Hospital Ethics Committee. Patients with a history of previous cardiac surgery or coagulation disorder or those who had received coumarin anticoagulants, heparin or acetylsalicylic acid within 5 days before surgery were not entered in the study. Written informed consent was obtained from 34 patients undergoing elective primary CABG.
Anaesthesia
Patients were premedicated with lorazepam 0.06 mg kg" 1 i.m. 2 h before induction of anaesthesia. The regular oral cardiovascular medication of the patients was given with the premedication. Consecutive patients were allocated randomly to one of two groups. The operating surgeon did not know to which group the patient belonged.
In the non-stress group, anaesthesia was induced with fentanyl 50 |ig kg" 1 , diazepam 0.3 mg kg" 1 and pancuronium 0.1 mg kg" 1 . A continuous infusion of fentanyl was started immediately after induction of anaesthesia, at a rate of 0.3 (ig kg" 1 min" 1 until the start of CPB and thereafter 0.15 ug kg" 1 min" 1 until the end of operation. When required, enflurane was administered to keep the systolic arterial pressure (SAP) less than 150mmHg during the prebypass period. Ephedrine, in 2.5-5 mg increments, was given to maintain SAP greater than 80 mm Hg. During CPB, mean arterial pressure was maintained between 30 and 80 mm Hg by giving either phenylephrine, in 100-200 ug increments, or by adding enflurane to the fresh gas flow of the oxygenator. After CPB, enflurane was administered when SAP was greater than 130 mm Hg.
In the stress group, anaesthesia was induced with thiopentone 2-4 mg kg" 1 , fentanyl 5 ug kg" 1 and pancuronium O.lmgkg" 1 . Thereafter, anaesthesia was maintained with enflurane. Enflurane was administered according to the same arterial pressure limits as in the fentanyl group before and during CPB. However, enflurane was given in inspiratory concentrations of at least 0.2 vol % to all patients in the enflurane group before and during CPB. After CPB, enflurane was administered as soon as SAP exceeded 90 mm Hg, if at the same time cardiac index was greater than 2.4 litre min" 1 m~! and there were no arrhythmias.
Diazepam 0.3 mg kg" 1 was administered during CPB to all patients in both groups. After operation, the patients were considered to be awake when they could give correct responses to two questions by moving the head or limbs. After CPB, dopamine and nitroglycerine infusions were given in both groups according to clinical criteria.
Cardiopulmonary bypass
During CPB, non-pulsatile flow and membrane oxygenation (Capiox, Terumo Corporation, Tokyo, Japan) were used. The extracorporeal circuit was primed with 2000 ml of Ringer's acetate solution. The patients were subjected to moderate systemic hypothermia (nasopharyngeal temperature 28-30 °C). The pump flow was maintained at 2.4 litre min" 1 m" 1 during cooling and rewarming, and at 1.6 litre min" 1 m" 2 during hypothermia. Topical myocardial cooling, together with intermittent cold potassium cardioplegia solution, were used for myocardial protection. PCV was maintained greater than 20 % during CPB by giving packed red cells. Administration of heparin and protamine was based on the individual heparin dose-activated coagulation time-response curves.
Fluid therapy
After induction of anaesthesia, one unit of blood was withdrawn from the patient and replaced with 1000 ml of Ringer's acetate solution. This autologous blood unit was given back to the patient after the available residual oxygenator perfusate had been returned after CPB. An additional dose of protamine 25 mg was given for each 500 ml of this residual oxygenator perfusate. Postoperative PCV was maintained at approximately 30 % by giving packed red cells and Ringer's acetate solution as required. Blood loss and total haemoglobin loss through the chest tubes were measured from sternal closure until the first morning after operation.
Laboratory analyses
Blood samples for laboratory analyses were collected into plastic syringes via a radial artery cannula. A slow saline infusion containing no heparin was used to maintain the patency of the cannula. Samples were taken at the following times: before operation after induction of anaesthesia; 15 min after the end of CPB; 2 h after CPB; 5.5 h after CPB; 16 h after CPB. An additional sample for measurement of plasma AVP was also obtained during CPB at maximal hypothermia. Plasma samples were frozen ( -70 °C) until the assay of hormones and coagulation factors. Protamine was given before the second sample. The autologous blood unit and residual oxygenator perfusate were returned to the patient between the second and third samples.
Plasma AVP concentration was measured using a previously described radioimmunoassay method [16] with an intra-assay coefficient of variation of 8 % and an inter-assay coefficient of variation of 14 %. Plasma catecholamine concentrations (noradrenaline and adrenaline) were measured using high pressure liquid chromatography with coulometric electrochemical detection (HPLC-EC), as reported previously [17] . The intra-assay coefficient of variation was 2 % and the inter-assay coefficient of variation was 3%.
PCV and platelet count in whole blood were determined using a Sysmex Analyzer (Toa Medical Electronics, Hamburg, Germany). Platelet adhesion was studied by measuring platelet retention on glass beads [18] . For the measurement, arterial blood was drawn through Adeplat S column at a constant flow rate using a Adeplat pump (Semmelweiss, Milano, Italy). After the first 2 ml of the effluent was discarded, platelet count in the third 1 ml was measured and subtracted from that in an aliquot of unfiitered blood. The difference in platelet counts (glass bead retention) was calculated in per cent of platelet count in the unfiitered blood and expressed as platelet adhesion. Template bleeding time determination (BT) was performed on the volar surface of the forearm with Simplate II device (General Diagnostics, Organon Teknika, Turnout, Belgium). Plasma P-thromboglobulin assay (p"-TG) was performed using a method described previously [19] .
Serum total protein concentration, plasma fibrinogen, activated partial thromboplastin time (APTT) and prothrombin time (PT) were determined using standard techniques, von Willebrand factor antigen (vWF) was assayed by immunoelectrophoresis [20] . Factor VIII procoagulant activity (factor VIII :C) was assayed with a one-stage kaolin-cephalin time method utilizing factor VIII: C-deficient plasma as a substrate [21] . The factor VIII:C-deficient plasma was obtained from a patient with severe haemophilia A (factor VIII:C<0.01 iuml-1 ). Factor V was assayed by one-stage prothrombin time technique [22] . The reference plasma for the determination of these coagulation factors was citrated plasma pooled from 20 healthy blood donors in Finnish Red Cross Blood Transfusion Service. Thromboelastograph (TEG) tracings (Hellige Company, Freiburg, Germany) were obtained from citrated whole blood. Coagulation was initiated by adding calcium chloride to the cuvettes. TEG tracings were analysed by measuring reaction time (R), coagulation time (R + K), clot formation (a-angle) and maximum amplitude [23] .
Statistical analyses
Analysis of variance (ANOVA) for repeated measurements was first applied for statistical comparisons within and between the groups. For statistical significance after ANOVA, the means were compared between and within the groups with Sheffe's F test. Within groups, the values were compared with the value obtained after the induction of anaesthesia. The values between the groups were compared at each sample time. Log-transformation was applied to hormone data before statistical analyses because of skewed data. Two-tailed Fisher's exact test was applied to compare data of quantal nature. The number of internal mammary artery grafts (one or two) was used as a covariate in the analysis of covariance for comparisons of blood loss and total haemoglobin loss between the groups. P < 0.05 was considered statistically significant. Results are given as the arithmetric mean with SEM or 95 % confidence limits, with the exception of the hormone results, which are presented as the geometric mean with 95% confidence limits.
RESULTS
Four of the 34 patients were excluded from the study. One of these had been allocated to the nonstress group. She had cardiac failure after operation and died soon after die operation. Three excluded patients had been allocated to the stress group. One had cardiac failure after operation and had to be treated with adrenaline. Two excluded patients required re-operation because of postoperative bleeding; the bleeding site was identified clearly in both. The haemostatic variables of these excluded patients did not differ from those of the remaining patients.
The final study groups were comparable in preoperative characteristics (table I) . There was a slightly greater proportion of male patients in the non-stress group; mean weight was slightly larger in the stress group. However, there was no significant difference between the groups in weight or body 63 (5) 103 (6) 244 (10) 51 (3) 4(0) 62 (3) 96 (8) 227(16) 46 (5) 3 (0) 3** 3(0) mass index (wt ht~2). In spite of the randomization, the number of patients with two internal mammary artery grafts was not similar in the groups (10 patients in the non-stress group vs three patients in the stress group; P = 0.025). All other intraoperative variables were comparable (table I) . The preoperative values of the coagulation variables were also similar in the groups (table II) . Awakening occurred significantly earlier in the stress group than in the non-stress group (87 (14) min vs 321 (102) min after the end of surgery; P < 0.001). Plasma concentration of AVP did not differ between the groups immediately after induction of anaesthesia ( fig. 1 ), but the AVP concentration was greater during CPB in the stress group than in the non-stress group (92.0 (50.7-133.2) pg ml" 1 vs 8.5 (5.1-11.9) pg ml" 1 ; P < 0.001) (data not shown in fig. 1 ). There was a significant difference between the groups immediately after CPB, because plasma AVP concentration increased 20-fold from the value after induction in the stress group ( fig. 1) . The plasma concentration of AVP was significantly greater in the stress group dian in the non-stress group at 2 h after CPB also. Until 5.5 h after CPB, plasma AVP concentration had increased also in the non-stress group, and there was no significant difference between the groups. On the first morning after operation, plasma AVP concentration had returned to the value after induction in both groups. Although there was a slightly greater proportion of females in the stress group, there was no difference in the AVP values between the sexes in the stress group.
Plasma concentrations of adrenaline and noradrenaline increased significantly in both groups immediately after CPB and remained increased until the end of the study. There was no significant difference between the groups at any stage ( fig. 1) .
PCV, serum total protein and platelet count decreased significantly after CPB in both groups (table II) . There were no significant differences between the groups in PCV and serum concentration of total protein at any stages of the study, but platelet count was greater in the stress group 2 h and 5.5 h after CPB and on the first morning after operation. The decrease in platelet adhesion was significant in the non-stress group immediately after CPB, but this decrease was not significantly different from that observed in the stress group. Platelet adhesion recovered within 2 h after CPB and remained recovered for the rest of the study in both groups (table II) . Plasma concentration of P-thromboglobulin increased significantly immediately after CPB in both groups, but had returned to the post-
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ttt tt induction value until the first morning after operation. The bleeding time was significantly prolonged 2 h and 5.5 h after CPB in both groups. There was no significant difference between the groups in plasma concentration P-thromboglobulin or bleeding time at any stage of the study (table II) . Plasma concentration of factor VIII :C did not change significantly in the two groups immediately after CPB ( fig. 2) but, because of a slight increase in the stress group and a slight decrease in the nonstress group, a significant difference in factor VIII: C concentration occurred between groups immediately after CPB. During the later course of the study, plasma concentration of factor VIII :C increased in both groups. Factor VIII :C concentration was increased significantly more in the stress group 2 h after CPB. However, 5.5 h after CPB and on the first morning after operation there was no difference between the groups. A similar course of changes was observed in von Willebrand factor. On the first morning after operation vWF concentration increased nearly two-fold in both groups compared with the postinduction values ( fig. 2) .
In both groups, plasma fibrinogen concentration decreased significantly after CPB, but returned to (7) 37 (3) the preoperative value until the first morning after operation (table II) . Factor V concentration declined significantly immediately after CPB in both groups, but returned to control values thereafter. However, on the first morning after operation, factor V concentration was significantly greater in the stress group. APTT values were slightly but significantly prolonged 15 min after CPB in both groups, but thereafter APTT values did not differ from the values after induction. PT values decreased from baseline during the whole study period. There was no significant difference between the groups in either APTT or PT. There were also no significant differences in any TEG parameter between the groups. TEG reaction time was significantly decreased from the value after induction on the first morning after operation in the non-stress group. TEG R + K time decreased significantly from postinduction values on the first morning after operation in both groups. Compared with the value after induction, TEG a-angle decreased significantly 15 min after CPB and increased significantly on the morning after operation in the stress group. The maximal amplitude of the TEG tracing decreased significantly 0.25 h and 2 h after CPB in the stress group.
Postoperative blood loss and total haemoglobin loss were significantly smaller (P = 0.0342 and 0.0224, respectively) in the stress group than in the non-stress group. After the number of internal mammary artery grafts was used as a covariate in the analysis of covariance, there were no statistically significant differences in blood loss and total haemoglobin loss between the groups (P = 0.162 and 0.222, respectively).
DISCUSSION
The present study confirmed our earlier finding that fentanyl, administered continuously in a large dose and supplemented with other anaesthetics, abolished the vasopressin response to cardiac surgery for as long as the opioid was infused [6] . However, this anaesthetic method is not totally "stress free", because similar catecholamine responses were noticed in both groups immediately after CPB. In contrast, and as expected, the enflurane-based anaesthetic method did not prevent the endocrine response to surgery. The increase in plasma concentration of AVP in the enflurane-anaesthetdzed patients (stress group) after CPB and thereafter and in the fentanyl-anaesthetized patients (non-stress group) after operation was associated temporally with an increase in plasma concentrations of von Willebrand factor and factor VIII. A similar relationship was not observed with plasma concentrations of catecholamines and the coagulation factors. These findings suggest that the stress-related increase in plasma concentration of AVP, or some other stress factors not identified in this study (but not catecholamines), may affect haemostasis in cardiac surgical patients after bypass.
Marked increases in plasma concentrations of numerous stress-related hormones, such as cortisol, AVP, noradrenaline and adrenaline, have been reported in association with cardiac surgery. Cardiopulmonary bypass seems to be a potent trigger to increase the concentrations of these hormones [2, 3] . The hormonal responses to CPB have been attenuated with the administrations of both i.v. [6] and volatile [24] anaesthetics. In our stress group, the anaesthetic (enflurane) concentration was adjusted according to the arterial pressure response, whilst the opioid was given in a fixed dose. Thus the level of anaesthesia might occasionally have been lighter in the volatile anaesthetic group. Therefore, our results do not allow us to grade one anaesthetic technique as superior to the other as far as suppression of the endocrine response to cardiac surgery is concerned.
We found that our fentanyl technique attenuated the vasopressin response to CPB, but did not abolish the catecholamine response. The inhibitory effect of fentanyl on the stress response seems to be mediated (directly or indirectly) via the hypothalamus [25] . This effect of fentanyl decreases the AVP release. The lack of effect of high-dose fentanyl on the sympathoadrenal response to CPB is in agreement with the observations of others [26, 27] .
AVP acts as an antidiuretic hormone at plasma concentrations of a few pg ml" 1 . However, under certain conditions such as surgery, considerably greater plasma AVP concentrations may prevail [10, 11, 28, 29] . These very large concentrations, known to induce vasocontriction, are associated with increases in plasma concentrations of factor VIII and vWF [10, 11] . Such a relationship existed also in our patients. Observations in studies using infusion of exogenous AVP to man suggest that there is a threshold plasma AVP concentration of 20-25 pg ml" 1 at which an increase in plasma concentration of factor VIII occurs [14, 15] . Our results agree with this suggestion, as a significant difference in plasma concentrations of vWF and factor VIII: C between the groups existed after CPB until the mean plasma concentration of AVP had increased to more than 20pgml~1. Our observations support the hypothesis that AVP has a physiological role in the acute regulation of haemostasis in surgical patients [30] . Increased catecholamine release does not seem to play a determinant role in the acute regulation of haemostasis. During colonoscopy, plasma concentrations of factor VIII :C and vWF increased with an increase in plasma concentration of AVP, while plasma catecholamine concentrations remained unchanged [29] . In our study, there was no difference in catecholamine concentrations between the groups.
Large molecular weight multimers of vWF act as a glue to overcome high shear forces between circulating platelets and collagen exposed by endothelial injury. Loss of glycoprotein Ib receptors which bind vWF to platelet surfaces may be an important part of acquired platelet dysfunction induced by CPB [31] . Clinical studies suggest that increases in concentrations of the adhesive agonist, vWF, to greater than those known to be critical for adequate haemostasis in non-cardiac surgery, may improve haemostasis after CPB [32, 33] . Although plasma concentrations of vWF did not decline to less than prebypass values, there was a difference in the plasma vWP concentration between the two groups and this may have a potential to cause a difference in haemostasis.
We did not observe significant differences between the groups in clotting times and coagulation factors other than factor VIII: C and vWF. However, we observed a greater platelet count in the stress group from 2 h after CPB until the first morning after operation. This finding is consistent with a previous report that stress (exercise-induced) produced a transient thrombocytosis via an effect on the spleen [34] . However, when we compared changes from the baseline values of platelet count between our two groups, there was no difference.
The blood loss and total haemoglobin loss measured after operation were significantly smaller in the stress group. However, the significant difference in the number of internal mammary artery grafts between groups may have affected this. It has been shown that the use of bilateral internal mammary artery grafts in CABG increases requirements for blood transfusion compared with one graft only [35] . To assess this, we used the number of these grafts as a covariate in the analysis of the data. With this procedure, there was no statistically significant difference in blood loss and haemoglobin loss between the groups. In order to reach statistical significance for the observed difference in blood loss or total haemoglobin loss between the groups, the sample size should have been about 100 patients with a statistical power of 0.80 and a significance level of 0.05. Thus the implications of the effects of anaesthesia on plasma AVP and coagulation factor concentrations on clinical haemostasis will require investigation in a much larger study.
The choice of the anaesthetic technique in patients undergoing CABG does not seem to affect postoperative cardiac complications and overall outcome [36, 37] . However, the method used to control surgical stress may contribute to the acquired haemostatic defect after CPB, by affecting the plasma concentrations of haemostatic factors.
